Sep 152020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA –  Aviceda Therapeutics, a pre-clinical stage biotech company focused on the next generation of glycol-immune therapeutics utilizing the Glyco-Code technology to address the innate immune system and chronic non-resolving inflammation today announced the appointment of two biopharma and business veterans, Dr. Chris Adams and Nancy Thomason to ...

Aviceda Therapeutics adds Dr. Chris Adams and Nancy Thomason to its Board of Directors

Aviceda Therapeutics adds Dr. Chris Adams and Nancy Thomason to its Board of Directors

From:: Aviceda Therapeutics adds Dr. Chris Adams and Nancy Thomason to its Board of Directors

Sorry, the comment form is closed at this time.